Waters has introduced Oasis PRiME MCX Cartridges and 96-Well Plates which selectively retain and concentrate basic compounds while removing up to 99% of phospholipids using methods. With the removal of the most abundant matrix interference, phospholipids, from biological matrices, scientists will simplify their analyses, improve method robustness and increase instrument uptime while getting the accurate information they need to make informed decisions.

“While it is accepted that sample cleanup provides many benefits, such as fewer matrix effects and lower limits of detection, many scientists avoid sample preparation simply because they do not have the time for method development. They want accurate results faster with the fewest steps possible,” said Kim Haynes, principal product marketing manager, Chemistry Technology Center.

“This is why we developed simple three- and four–step protocols to go along with Oasis PRiME MCX that deliver consistently and reproducibly cleaner samples faster than conventional mixed-mode SPE methods. Ultimately, this gives scientists greater confidence in their quantitative test results in support of clinical trial, clinical research, forensic toxicology, food or environmental studies.”

The company’s proprietary manufacturing processes for the cartridges and multi-well plates are optimized to increase flow reproducibility when using positive pressure or vacuum manifolds so that processing times are more predictable.

Oasis PRiME MCX Cartridges and 96-Well Plates are now available from Waters worldwide. Oasis PRiME MCX joins Oasis PRiME HLB, Ostro, Sep-Pak, Oasis HLB and Oasis Mixed Mode IEX in Waters market leading portfolio of sample preparation products.